Description
The abstract explicitly states that ‘the mechanisms of synaptic clearance in AD remain to be investigated’ despite TREM2’s known involvement. Understanding these mechanisms is critical for developing targeted therapeutics that could preserve synaptic function in early AD.
Gap type: open_question Source paper: The Specific Mechanism of TREM2 Regulation of Synaptic Clearance in Alzheimer’s Disease. (2022, Frontiers in immunology, PMID:35663962)
Resolution criteria
Resolved when an evidence artifact establishes the specific molecular mechanisms by which TREM2 regulates synaptic clearance in AD, with one of: (1) co-immunoprecipitation and mass spectrometry in TREM2-expressing cells or brain tissue identifying the TREM2 interactome during synaptic engulfment, with >=3 confirmed protein-protein interactions (e.g., TREM2-DAP12, TREM2-Syk, TREM2-PI3K) validated by reverse IP or proximity ligation assay (PLA); (2) synaptic engulfment assays in iPSC-derived microglia from TREM2 R47H/H/D risk variant carriers versus non-carriers, showing >=40% reduced synaptic debris clearance with quantitative measurement (flow cytometry or ImageStream) and rescue by TREM2 lentiviral overexpression; (3) mechanistic studies using TREM2-deficient mice (TREM2 KO or R47H KI) with synaptic labeling (PSD95-SAP or synaptophysin antibody) and electron microscopy, demonstrating that microglial synaptic engulfment requires TREM2-mediated phagocytic signaling (>=50% reduction in engulfed synaptic elements). The artifact must link the mechanism to AD-relevant synaptic loss pathways.
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:22.517633+00:00”, “resolution_summary”: “Resolved by hypothesis h-5d68a7d2: Microglial TREM2 Activation to Enhance Synaptic Pruning Regulation. Supporting evidence includes debate sess_SDA-2026-04-06-gap-pubmed-20260406-062118-e3613755_task_9aae8fc5.”, “match_counts”: {“hypothesis_matches”: 2, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-5d68a7d2”, “title”: “Microglial TREM2 Activation to Enhance Synaptic Pruning Regulation”, “score”: 0.327, “reason”: “3 token overlaps; entity overlap: trem2”, “analysis_id”: “SDA-2026-04-16-frontier-connectomics-84acb35a”, “target_gene”: “Microglial TREM2”, “target_pathway”: null, “disease”: “connectomics”, “composite_score”: 0.53463, “confidence_score”: 0.65, “status”: “proposed”, “pubmed_evidence_ids”: [“19219025”, “26551527”, “26928458”, “29186337”, “31171641”]}, {“id”: “h-d5dea85f”, “title”: “Microglial Senescence Prevention via TREM2/SASP Axis”, “score”: 0.222, “reason”: “15 token overlaps; entity overlap: trem2”, “analysis_id”: “SDA-2026-04-16-gap-pubmed-20260410-150544-e3a2eab9”, “target_gene”: “TREM2”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.837096, “confidence_score”: 0.48, “status”: “proposed”, “pubmed_evidence_ids”: [“28602351”, “28802038”, “30738892”, “31902528”, “31932797”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-06-gap-pubmed-20260406-062118-e3613755_task_9aae8fc5”, “title”: “The study shows SPP1 from perivascular cells drives microglial synaptic engulfment, but the specific receptors, signaling pathways, and molecular cascades linking SPP1 to phagocytic gene expression remain undefined. Understanding this mechanism is critical for developing targeted therapeutics that could modulate pathological synaptic loss.\n\nGap type: unexplained_observation\nSource paper: Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer’s disease. (2023, Nat Neurosci, PMID:36747024)”, “score”: 0.565, “reason”: “14 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-06-gap-pubmed-20260406-062118-e3613755”, “quality_score”: 0.704, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260411-072446-a32fa49c”, “title”: “The abstract shows TYROBP deficiency is neuroprotective despite being required for TREM2, CD33, and CR3 function - receptors associated with AD risk. This counterintuitive finding challenges current understanding of how these immune receptors contribute to AD pathogenesis.\n\nGap type: contradiction\nSource paper: Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer’s pathology. (None, None, PMID:28612290)”, “score”: 0.53, “reason”: “9 token overlaps; entity overlap: pmid, trem2”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260411-072446-a32fa49c”, “quality_score”: 0.56, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062207-e4ce5cf0_task_9aae8fc5”, “title”: “The abstract mentions that pathological seeds have different characteristics and conformations, but the underlying molecular mechanisms that generate this diversity remain unclear. Understanding these mechanisms is critical for developing targeted therapeutic interventions.\n\nGap type: unexplained_observation\nSource paper: Protein transmission in neurodegenerative disease. (2020, Nat Rev Neurol, PMID:32203399)”, “score”: 0.5, “reason”: “11 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062207-e4ce5cf0”, “quality_score”: 0.65, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260411-075338-35f913fb”, “title”: “The abstract shows HDAC9 overexpression reduces Aβ deposition and improves synaptic deficits, but the underlying molecular pathways are not explained. Understanding these mechanisms is critical for developing HDAC9-targeted therapeutics for AD.\n\nGap type: unexplained_observation\nSource paper: Neuronal HDAC9: A key regulator of cognitive and synaptic aging, rescuing Alzheimer’s disease-related phenotypes. (2026, Mol Psychiatry, PMID:41935184)”, “score”: 0.487, “reason”: “11 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260411-075338-35f913fb”, “quality_score”: 0.95, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-15-gap-pubmed-20260411-075338-35f913fb_20260416-034701”, “title”: “The abstract shows HDAC9 overexpression reduces Aβ deposition and improves synaptic deficits, but the underlying molecular pathways are not explained. Understanding these mechanisms is critical for developing HDAC9-targeted therapeutics for AD.\n\nGap type: unexplained_observation\nSource paper: Neuronal HDAC9: A key regulator of cognitive and synaptic aging, rescuing Alzheimer’s disease-related phenotypes. (2026, Mol Psychiatry, PMID:41935184)”, “score”: 0.487, “reason”: “11 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-15-gap-pubmed-20260411-075338-35f913fb”, “quality_score”: 0.71, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}